Patent · US Active

CNP prodrugs with carrier attachment at the ring moiety

US12156917B2 · kind B2 · utility

0Cited by

17References

13Claims

0Family size

Assignee

ASCENDIS PHARMA GROWTH DISORDERS A/S · DK

Inventors

Harald Rau · Würzburg, DE
Ulrich Hersel · Heidelberg, DE
Felix Cleemann · Mainz, DE
Kennett Sprogøe · Rudegård, DK

Key dates

Filing date	Jun 16, 2022
Grant date	Dec 3, 2024
Priority date	—
Expiry date	Jun 16, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P19/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to CNP prodrugs in which the carrier is covalently and reversibly attached to the ring moiety of a CNP moiety, to pharmaceutical compositions comprising such CNP prodrugs, to their uses and to methods of treating diseases that can be treated with the CNP prodrugs of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.